New antiprotozoal agents: Synthesis and biological evaluation of different 4-(7-chloroquinolin-4-yl) piperazin-1-yl)pyrrolidin-2-yl)methanone derivatives

In an endeavor to develop efficacious antiprotozoal agents 4-(7-chloroquinolin-4-yl) piperazin-1-yl)pyrrolidin-2-yl)methanone derivatives (5–14) were synthesized, characterized and biologically evaluated for antiprotozoal activity. The compounds were screened in vitro against the HM1: IMSS strain of Entamoeba histolytica and NF54 chloroquine-sensitive strain of Plasmodium falciparum. Among the synthesized compounds six exhibited promising antiamoebic activity with IC₅₀ values (0.14–1.26 μM) lower than the standard drug metronidazole (IC₅₀ 1.80 μM). All nine compounds exhibited antimalarial activity (IC₅₀ range: 1.42–19.62 μM), while maintaining a favorable safety profile to host red blood cells. All the compounds were less effective as an antimalarial and more toxic (IC₅₀ range: 14.67–81.24 μM) than quinine (IC₅₀: 275.6 ± 16.46 μM) against the human kidney epithelial cells. None of the compounds exhibited any inhibitory effect on the viability of Anopheles arabiensis mosquito larvae.     

A colorimetric method for the evaluation of anti-giardial drugs in vitro

The aim of this study was to develop a simple and reliable method to determine the viability of Giardia intestinalis after incubation with an anti-giardial agent by using a colorimetric method. Factors that may affect the optical density value were systematically evaluated. The most suitable conditions were obtained when G. intestinalis trophozoites, 5 × 10⁵ cells/ml were incubated with the anti-giardial agent for 48 h. The culture medium was removed and trophozoites were immediately fixed by immersing the whole plate in absolute methanol for 2 min. The fixed trophozoites were then stained with 0.1% w/v methylene blue for 10 min, washed once by immersing the whole plate into distilled water. The dye was released by adding 0.1 M hydrochloric acid solution (300 μl) and the optical density was read at 655 nm. The 50% inhibitory concentration values (IC₅₀) of metronidazole, ornidazole and furazolidone obtained from our proposed method (0.41 ± 0.06, 0.18 ± 0.01, 0.26 ± 0.13 μg/ml, respectively) were comparable to the IC₅₀ values obtained by the current conventional method (0.14 ± 0.05, 0.15 ± 0.04, 0.14 ± 0.02 μg/ml, respectively). This new method did provide a convenient and reliable way to screen for potential anti-giardial agents.     

Design,synthesis and biological evaluation of metronidazole–thiazole derivatives as antibacterial inhibitors

A series of metronidazole–thiazole derivatives has been designed, synthesized and evaluated as potential antibacterial inhibitors. All the synthesized compounds were determined by elemental analysis, ¹H NMR and MS. They were also tested for antibacterial activity against Escherichia coli, Bacillus thuringiensis, Bacillus subtilis and Pseudomonas aeruginosa as well as for the inhibition to FabH. The results showed that compound 5e exhibited the most potent inhibitory activity against E. coli FabH with IC₅₀ of 4.9 μM. Molecular modeling simulation studies were performed in order to predict the biological activity of proposed compounds. Toxicity assay of compounds 5a, 5b, 5d, 5e, 5g and 5i showed that they were noncytotoxic against human macrophage. The results revealed that these compounds offered remarkable viability.     

尼美舒利联合甲硝唑对牙周炎患者血清IL-10、TNF-α和MMP-8水平的影响

目的:研究尼美舒利联合甲硝唑对牙周炎患者血清白细胞介素-10(IL-10)、肿瘤坏死因子(TNF-α)、基质金属蛋白酶-8(MMP-8)水平的影响。方法:收集2014年3月至2015年3月我院收治的90例牙周炎患者,按照抽签法分为实验组和对照组,每组各45例。两组均采用牙结石以及牙菌斑除去、根面平整、冲洗牙周袋等常规治疗。对照组在此基础上采用甲硝唑治疗,0.9%生理盐水进行冲洗。实验组在对照组基础上采用尼美舒利治疗,每次2片,每天2次。观察和比较两组的治疗疗效,牙周情况,治疗前后血清IL-10、TNF-α、MMP-8水平的变化及不良反应的发生情况。结果:治疗后,实验组总有效率显著高于对照组(P0.05);GI、PD、PLI、AL显著低于对照组(P0.05);血清IL-10水平显著高于对照组(P0.05),血清TNF-α、MMP-8水平显著低于对照组(P0.05);两组不良反应总发生率比较差异无统计学意义(P0.05)。结论:尼美舒利联合甲硝唑治疗牙周炎可显著提高其临床疗效,消除或缓解临床症状,可能与其提高血清IL-10水平,降低TNF-α、MMP-8水平,抑制炎症反应,保持牙内环境稳定有关。     

利用甲硝唑及外加氧方法筛选耐氧产氢Klebsiella oxytoca HP1突变菌株

摘氢酶是生物制氢的关键酶,大多数氢酶因对氧极敏感而易失活,因此提高氢酶的氧耐受性对生物制氢有重要意义。本研究利用1％甲基磺酸乙酯对Klebsiella oxytoca HPl进行了两轮诱变,经40mmol／L甲硝唑和21％氧联合处理1h（第一轮诱变）或2h（第二轮诱变）进行筛选。所得突变菌株经产氢测试,结果在15％氧浓度条件下,第一代突变菌株HPl-A15产氢活性为出发菌株Klebsiella oxytoca HPl的3.70倍,在21％氧浓度条件下第二代突变菌株HPAl5-37产氢活性为HPl-A15菌株的2.75倍,是出发菌株的11倍。突变菌株HPl-A15和HPAl5-37具有较好的遗传稳定性。本试验结果说明利用MNZ和外加氧的方法适用于兼性厌氧菌耐氧产氢突变菌株的筛选。     

Treatment of nonspecific diarrhea with metronidazole in rhesus macaques

Nonspecific diarrhea was successfully treated with metronidazole in 76% (13/17) of cases in adult rhesus macaques (Macaca mulatta). Effective treatment was achieved by oral administration of metronidazole daily at a low dose of 250 mg for at least eight days or at high daily doses of 500-1,500 mg for one to four days. Minimal effective total dose was 1500 mg. Apart from occasional vomiting, no side effects were observed.     

Control of hydrogen-dependent nitrogenase activity by adenylates and electron flow in heterocysts of Anabaena variabilis (ATCC 29413)

Hydrogen-dependent nitrogenase activity was studied in heterocysts, isolated from the filamentous cyanobacterium Anabaena variabilis (ATCC 29413). Hydrogen provides reductant and ATP for nitrogenase via linear electron flow through Photosystem I. This allows for regulation of nitrogenase activity by controlling the turnover of the photosystem. When nitrogenase activity was varied by changing either the light intensity or the supply of reductant (i.e., hydrogen) or by inhibition of photosynthetic electron transport by DBMIB, no rate-dependent changes in cellular ATP concentrations were observed. This homeostasis of ATP was perturbed by addition of metronidazole, acting as alternative electron sink to nitrogenase, and by uncoupling agents like FCCP, gramicidin and nigericin. Valinomycin (in presence of KCl) exerted little effect on nitrogenase activity and adenylate pool composition. Metronidazole increased and uncoupling agents decreased cellular ATP concentration, ATP/ADP ratio and energy charge. Inhibition of nitrogenase activity by metronidazole was caused by reductant limitation; inhibition by uncoupling agents was due to energy limitation. Control exerted on nitrogenase activity by ATP (energy limitation) was more pronounced at high rates of electron flow to nitrogenase than during reductant limitation. When cellular ATP synthesis was suboptimal due to partial uncoupling, the connection of phosphorylation and nitrogenase activity by electron transport allowed for homeostasis of ATP also at a lowered cellular concentration.     

The differential action of metronidazole on nitrogen fixation,hydrogen metabolism,photosynthesis and respiration in Anabaena and Scenedesmus

Metronidazole (2-methyl-5-nitroimidazole-1-ethanol) at 1–2 mM levels has been shown to be a selective inhibitor of nitrogenase activity in Anabaena. Two constitutive hydrogenases and photosynthesis are insensitive to metronidazole at these same concentrations. At higher concentrations metronidazole inhibits photosynthesis in Anabaena while photoreduction and to a lesser extent photohydrogen production are retarded in Scenedesmus. Respiration is slightly stimulated at high metronidazole levels in both algae. The reductant source for nitrogenase in Anabaena and photohydrogen production and photoreduction electron transport in Scenedesmus are discussed. Due to the activity of metronidazole as a selective inhibitor of ferredoxin-associated processes, it should prove to be useful in N₂ fixation studies and in distinguishing between ferredoxin-linked reactions of different sensitivities and other activities not associated with low reduction potential components.     

Metronidazole aryloxy,carboxy and azole derivatives: Synthesis,anti-tumor activity,QSAR, molecular docking and dynamics studies

A series of novel metronidazole aryloxy, carboxy and azole derivatives has been synthesized and their cytotoxic activities on three cancer cell lines were evaluated by MTT assay. Compounds 4m, 4l and 4d showed the most potent cytotoxic activity (IC₅₀s?less than?100?µg/mL). Apoptosis was also detected for these compounds by flow cytometry. Docking studies were performed in order to propose the probable target protein. In the next step, molecular dynamics simulation was carried out on the proposed target protein, focal adhesion kinase (FAK, PDB code: 2ETM), bound to compound 4m. As, 4m showed a potent cytotoxic activity and an acceptable apoptotic effect, it can be a potential anticancer candidate that may work through inhibition of FAK.     

乳杆菌活菌胶囊治疗细菌性阴道病的疗效观测

目的观察甲硝唑和乳杆菌活菌胶囊（商品名定君生）联合用药治疗细菌性阴道病的疗效。方法68例细菌性阴道病患者随机分成2组各34例,A组用甲硝唑0．5g塞阴道,每日1次,共7d,同时用定君生胶囊0．25g塞阴道,每日1次,共10d。B组单用硝唑栓0．5g塞阴道。结果停药后7d复查,A组有效率为91．17％,B组有效率为85．29％,2组差异无统计学意义;治疗3个月复查,A组有效率为88．23％,B组有效率为67．47％,2组差异有统计学意义。结论甲硝唑联合定君生治疗细菌性阴道病疗效确切,复发率低,是目前治疗细菌性阴道病的较好方法,值得推广使用。